Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Temporal analysis of type 1 interferon activation in tumor cells following external beam radiotherapy or targeted radionuclide therapy

Theranostics(2021)10.7150/thno.54881Source: DataRank Database

Temporal analysis of type 1 interferon activation in tumor cells following external beam radiotherapy or targeted radionuclide therapy is a research paper published in Theranostics (2021). On theSindex it has a DataRank of 0. It has been cited 80 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access80 citations

Download PDF

Cite:

Linked data & code

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (23 grants)OA: goldTopics (52)Linked Datasets (6)DataCite Reuse (6)IDs (PubMed, PMC)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (2/2)

Has DOI
Indexed in repositories

Accessible (1/2)

Open Access

Interoperable (2/2)

DataCite relations
Linked datasets

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (24)

Won Jong Jin ORCID,Amber M. Bates ORCID,Reinier Hernandez ORCID,Joseph J. Grudzinski ORCID,Ian R. Marsh ORCID

Live enrichment

PubMed:33995649 PMC:PMC8120207

NCI NIH HHS

Grant: F30 CA250263

NCI NIH HHS

Grant: K08 CA241319

NCI NIH HHS

Grant: P30 CA047904

NIDCR NIH HHS

Grant: P50 DE026787

NIGMS NIH HHS

Grant: T32 GM008692

NCI NIH HHS

Grant: P01 CA250972

NCATS NIH HHS

Grant: TL1 TR002375

NCI NIH HHS

Grant: U01 CA224166

NCI NIH HHS

Grant: U01 CA233102

NIH HHS

Grant: DP5 OD024576

NIH HHS

Grant: S10 OD028670

NCI NIH HHS

Grant: P30 CA014520

NCI NIH HHS

Grant: T32 CA009206

National Institutes of Health

Grant: 5U01CA233102-04

Immunomodulation of the Tumor Microenvironment with Molecular Targeted Radiotherapy to Facilitate an Adaptive Anti-Tumor Immune Response to Combined Modality Immunotherapies

National Institutes of Health

Grant: 5K08CA241319-04

Utilization of molecular targeted radionuclides to prime immune responses at local and distant metastatic tumor sites

National Institutes of Health

Grant: 5F30CA250263-02

Brachytherapy to achieve in situ cancer vaccination

National Institutes of Health

Grant: 5DP5OD024576-02

Combining Radiation and Tumor-specific AntIbody Therapies to Elicit in Situ Tumor Vaccination

National Institutes of Health

Grant: 1S10OD028670-01

UW SPECT/CT Acquisition

National Institutes of Health

Grant: 5T32GM008692-22

Integrated Training For Physician-Scientists

National Institutes of Health

Grant: 5TL1TR002375-04

NRSA Training Core

National Institutes of Health

Grant: 5P01CA250972-02

Molecular Targeted Radionuclide Therapy for Tumor Immunomodulation and Enhancing Immunotherapy Response

National Institutes of Health

Grant: 5P50DE026787-02

Head and Neck Cancer SPORE at the University of Wisconsin

National Institutes of Health

Grant: 5P30CA014520-18

CANCER CENTER SUPPORT

goldLicense: cc-by

publisherhttps://doi.org/10.7150/thno.54881

publisherhttps://www.thno.org/v11p6120.htm

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/8120207

Europe_PMChttps://europepmc.org/articles/PMC8120207

Europe_PMChttps://europepmc.org/articles/PMC8120207?pdf=render

Fields of Study

03 medical and health sciences0302 clinical medicine

MeSH Terms

LymphocytesCell Line, TumorAnimalsMice, Inbred C57BLMiceMelanoma, ExperimentalCarcinoma, Squamous CellHead and Neck NeoplasmsYttrium RadioisotopesInterferon Type IMembrane ProteinsNeoplasm ProteinsRadiopharmaceuticalsCombined Modality TherapyTumor Stem Cell AssayDose-Response Relationship, RadiationGene Expression Regulation, NeoplasticUp-RegulationTime FactorsFemaleGene Knockout TechniquesImmune Checkpoint InhibitorsTumor Protein, Translationally-Controlled 1STING Protein

Keywords

External Beam RadiotherapyCheckpoint BlockadeType 1 InterferonTargeted Radionuclide TherapyImmune SusceptibilityTime FactorsMelanoma, ExperimentalMembrane ProteinsTumor Protein, Translationally-Controlled 1Dose-Response Relationship, RadiationCombined Modality TherapyNeoplasm ProteinsGene Expression Regulation, NeoplasticMice, Inbred C57BLGene Knockout TechniquesMiceHead and Neck NeoplasmsCell Line, TumorInterferon Type ICarcinoma, Squamous CellAnimalsFemaleLymphocytesRadiopharmaceuticalsImmune Checkpoint InhibitorsResearch Paper

Sustainable Development Goals

SDG 3: 3. Good health

Additional file 1 of Differential reinforcement of cGAS-STING pathway-involved immunotherapy by biomineralized bacterial outer membrane-sensitized EBRT and RNT

10.6084/m9.figshare.25963103.v1figshare

Additional file 1 of Differential reinforcement of cGAS-STING pathway-involved immunotherapy by biomineralized bacterial outer membrane-sensitized EBRT and RNT

10.6084/m9.figshare.25963103figshare

Additional file 1 of Estrogen receptor blockade and radiation therapy cooperate to enhance the response of immunologically cold ER+ breast cancer to immunotherapy

10.6084/m9.figshare.26596985.v1figshare

Additional file 1 of Estrogen receptor blockade and radiation therapy cooperate to enhance the response of immunologically cold ER+ breast cancer to immunotherapy

10.6084/m9.figshare.26596985figshare

Additional file 2 of Estrogen receptor blockade and radiation therapy cooperate to enhance the response of immunologically cold ER+ breast cancer to immunotherapy

10.6084/m9.figshare.26596988.v1figshare

Additional file 2 of Estrogen receptor blockade and radiation therapy cooperate to enhance the response of immunologically cold ER+ breast cancer to immunotherapy

10.6084/m9.figshare.26596988figshare